Found: 32
Select item for more details and to access through your institution.
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.
- Published in:
- Clinical Colorectal Cancer, 2015, v. 14, n. 3, p. 162, doi. 10.1016/j.clcc.2015.02.006
- By:
- Publication type:
- Article
COVID‐19 and liver cancer clinical trials: Not everything is lost.
- Published in:
- Liver International, 2020, v. 40, n. 7, p. 1541, doi. 10.1111/liv.14532
- By:
- Publication type:
- Article
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
- By:
- Publication type:
- Article
Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 3, p. 428, doi. 10.1007/s10120-016-0625-1
- By:
- Publication type:
- Article
Tumour burden score and immune‐related hepatotoxicity in patients with hepatocellular carcinoma or liver metastases treated with immune checkpoint inhibitors.
- Published in:
- Liver Cancer International, 2022, v. 3, n. 2, p. 63, doi. 10.1002/lci2.51
- By:
- Publication type:
- Article
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2013, v. 18, n. 4, p. 379, doi. 10.1634/theoncologist.2012-0221
- By:
- Publication type:
- Article
Achievements in Systemic Therapies in the Pregenomic Era in Metastatic Breast Cancer.
- Published in:
- Oncologist, 2007, v. 12, n. 3, p. 253, doi. 10.1634/theoncologist.12-3-253
- By:
- Publication type:
- Article
KRAS mutation in lung metastases from colorectal cancer: prognostic implications.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 2, p. 256, doi. 10.1002/cam4.592
- By:
- Publication type:
- Article
Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Drugs & Aging, 2021, v. 38, n. 7, p. 579, doi. 10.1007/s40266-021-00871-5
- By:
- Publication type:
- Article
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
- By:
- Publication type:
- Article
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 7, p. 1179, doi. 10.1007/s00432-013-1429-x
- By:
- Publication type:
- Article
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 6, p. 1676, doi. 10.1245/s10434-018-6387-8
- By:
- Publication type:
- Article
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases.
- Published in:
- World Journal of Surgery, 2018, v. 42, n. 8, p. 2651, doi. 10.1007/s00268-018-4525-x
- By:
- Publication type:
- Article
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Diagnostic accuracy of C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 9, p. 1399, doi. 10.1007/s00259-015-3079-5
- By:
- Publication type:
- Article
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2 / neu-positive breast cancer cells.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 10, p. 3016, doi. 10.1002/1521-4141(2001010)31:10<3016::AID-IMMU3016>3.0.CO;2-J
- By:
- Publication type:
- Article
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5834, doi. 10.3390/cancers14235834
- By:
- Publication type:
- Article
Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3952, doi. 10.3390/cancers14163952
- By:
- Publication type:
- Article
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5665, doi. 10.3390/cancers13225665
- By:
- Publication type:
- Article
Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4506, doi. 10.3390/cancers13184506
- By:
- Publication type:
- Article
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3370, doi. 10.3390/cancers12113370
- By:
- Publication type:
- Article
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-619
- By:
- Publication type:
- Article
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 10, p. 1726, doi. 10.3390/jpm12101726
- By:
- Publication type:
- Article
Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/jpm12020204
- By:
- Publication type:
- Article
Metabolic Switch in Hepatocellular Carcinoma Patients Treated with Sorafenib: a Proof-of-Concept Trial.
- Published in:
- Molecular Imaging & Biology, 2020, v. 22, n. 5, p. 1446, doi. 10.1007/s11307-020-01489-6
- By:
- Publication type:
- Article
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 99, n. 5, p. 310
- By:
- Publication type:
- Article
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article